These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 2564140)
41. The impact of direct-to-consumer advertising. Lewis C FDA Consum; 2003; 37(2):8. PubMed ID: 12715762 [No Abstract] [Full Text] [Related]
42. [Parapharmaceutical advertising and its control (law no. 72-7 of 3 January 1972)]. Doll PJ Med Leg Dommage Corpor; 1972; 5(4):359-62. PubMed ID: 4679040 [No Abstract] [Full Text] [Related]
43. Direct-to-consumer prescription drug advertising. Talley CR Am J Health Syst Pharm; 1997 Oct; 54(19):2181. PubMed ID: 9331437 [No Abstract] [Full Text] [Related]
45. DTCA not real advertising issue. Saunders B N Z Med J; 2003 Sep; 116(1182):U611. PubMed ID: 14581960 [No Abstract] [Full Text] [Related]
46. Direct-to-consumer advertising--where does the public interest lie? Saunders B N Z Med J; 2003 Aug; 116(1180):U557; discussion U557. PubMed ID: 14581978 [No Abstract] [Full Text] [Related]
47. Functional foods: health boon or quackery? Jacobson MF; Silverglade B BMJ; 1999 Jul; 319(7204):205-6. PubMed ID: 10417063 [No Abstract] [Full Text] [Related]
48. Consumer advertising of prescription drugs. Hayes AH Pa Med; 1983 Dec; 86(12):50-1. PubMed ID: 6689364 [No Abstract] [Full Text] [Related]
49. Impact of direct-to-consumer advertising on healthcare providers and consumers. Mahon SM Clin J Oncol Nurs; 2006 Jun; 10(3):417-20. PubMed ID: 16789585 [No Abstract] [Full Text] [Related]
50. FDA revisits DTC advertising. Young D Am J Health Syst Pharm; 2005 Dec; 62(24):2580, 2582-3. PubMed ID: 16333052 [No Abstract] [Full Text] [Related]
51. ["Illegitimate children and the medical sciences"--quackery in Tidsskriftet 1990-24]. Lillestøl K; Schiøtz A Tidsskr Nor Laegeforen; 2011 Dec; 131(24):2512-6. PubMed ID: 22170145 [No Abstract] [Full Text] [Related]
52. Direct-to-consumer advertising: developing evidence-based policy to improve retention and comprehension. Riggs DL; Holdsworth SM; McAvoy DR Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-249-52. PubMed ID: 15452004 [TBL] [Abstract][Full Text] [Related]
53. [An analysis of medical advertising]. Abraham RE Ned Tijdschr Geneeskd; 1967 Feb; 111(5):205-10. PubMed ID: 6042283 [No Abstract] [Full Text] [Related]
54. Portrayal of the elderly in prescription drug advertising. A pilot study. Smith MC Gerontologist; 1976 Aug; 16(4):329-34. PubMed ID: 1026575 [No Abstract] [Full Text] [Related]
55. Dealing with drug advertising. The FDA can't always enforce the rules on misleading ads. Atkinson HG Health News; 2003 Feb; 9(2):5. PubMed ID: 12632541 [No Abstract] [Full Text] [Related]
56. [A contribution to the development of advertising in pharmacy II. Historical development of regulation of advertising of medicinal products]. Vranová V Ceska Slov Farm; 2012 Oct; 61(5):240-3. PubMed ID: 23256658 [TBL] [Abstract][Full Text] [Related]
57. [Name of drugs and advertising]. Rafaelsen OJ Nord Med; 1976 Jun; 91(6-7-1):195. PubMed ID: 934800 [No Abstract] [Full Text] [Related]
58. Direct-to-the-consumer advertising of drug products. Uzych L Pa Med; 1993 Jul; 96(7):16-7. PubMed ID: 8414594 [TBL] [Abstract][Full Text] [Related]
59. [Advertising and journal information on drugs]. Tidsskr Nor Laegeforen; 1970 Mar; 90(5):506. PubMed ID: 5426207 [No Abstract] [Full Text] [Related]
60. Direct-to-consumer drug advertising: you get what you pay for. Jeffords JM Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-253-5. PubMed ID: 15452003 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]